Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.

Court of Appeals for the Federal Circuit·Decided September 3, 2024·No. 23-2219·Unpublished

Opinion

Case: 23-2219 Document: 19 Page: 1 Filed: 09/03/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellant

v.

TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., Defendants-Appellees ______________________

2023-2219 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-01979-RGA, Judge Richard G. Andrews. ______________________

ORDER Upon consideration of the parties’ joint stipulation of voluntary dismissal of this appeal, pursuant to Federal Rule of Appellate Procedure 42(b)(1), ECF No. 18, IT IS ORDERED THAT: (1) The appeal is voluntarily dismissed. Case: 23-2219 Document: 19 Page: 2 Filed: 09/03/2024

(2) Each side shall bear its own costs. FOR THE COURT

September 3, 2024 Date

ISSUED AS A MANDATE: September 3, 2024

Free access — add to your briefcase to read the full text and ask questions with AI

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., (Fed. Cir. 2024).

Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc. (Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.